$IVOB Could Expand the INVO Empire with Financing
December 21st, 2009 at 3:48 pm Posted by
News out for $IVOB this afternoon, although The Dean has noticed that the press release hasn’t “hit all wires,” such as Yahoo! and Google (NASDAQ: GOOG). Nevertheless, The Dean’s excited to learn that $IVOB has filed a preliminary prospectus for the sale of up to 8.79 million shares to AGS Capital Group, as part of an equity financing agreement.
Some could view this as a negative but The Dean, and the CollegeStock Community, who have been tenaciously following $IVOB‘s potential to become The Dean’s Billion Dollar Baby, see this as an indication that the company not only has a sound business plan but is also setting that plan into action and doing what’s necessary to make their FDA dreams and Pregnant Profits a reality.
The release from Boston Business Journal (and MassDevice.com) reiterates the fact that $IVOB has potential to receive up to $10 million in the next two years and close to $3 million (8.79 million shares @ $0.32/share) in the shorter term. The Dean thinks such funds could be used for clinical trials necessary for 510(k) clearance.
In addition, $IVOB could reap benefits from this funding agreement by further expanding its INVO Empire to other countries on the [in]fertile soils of 5 continents where their INVOcell device has already touched down and gone to work.
We also learn that $IVOB saw sales of $56,300 during the first nine months of 2009, which is a significant development compared to no revenue during the same time period in 2008. As of the end of September, $IVOB had reported $194,000 cash in the bank and The Dean believes that’s just a drop in the hat for $IVOB.
